ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
POSTER <str<strong>on</strong>g>ABSTRACTS</str<strong>on</strong>g><br />
<strong>CRRT</strong> 2012 PROGRAM/INDEX<br />
51. Survival and Mortality Risk Factors in Mexican Patients with Acute Kidney Injury …………………………………………………………………162<br />
Luis A Evangelista-Carrillo<br />
52. The Impact of the Daily Presence of the Nephrology Resident in the Postoperative Cardiac Intensive Care Unit ……………………………………162<br />
César Flores-Gama<br />
53. A New Clinical Score to Predict Acute Kidney Injury After Cardiac Surgery in Chinese Elderly Patients……………………………………………164<br />
Penghua Hu<br />
54. The Impact of Acute Kidney Injury <strong>on</strong> In-Hospital Morbidity and Mortality Am<strong>on</strong>g Patients With and Without Baseline<br />
Chr<strong>on</strong>ic Kidney Disease ………………………………………………………………………………………………………………………………………164<br />
Mira T Keddis<br />
55. Clinical Study of 72 Pediatric Patients who were Performed Extracorporeal Membrane Oxygenati<strong>on</strong> with <strong>CRRT</strong> …………………………………165<br />
Hirotsugu Kitaymaa<br />
56. Acute Kidney Injury Does Not C<strong>on</strong>tribute Towards Mortality in Intensive Care Unit Patients ………………………………………………………166<br />
Harbir S Kohli<br />
57. The Usefulness of AKIN Criteria Predict L<strong>on</strong>g Term Outcome of Hospital-Acquired Acute Kidney Injury …………………………………………167<br />
So<strong>on</strong> Hyo Kw<strong>on</strong><br />
58. The Impact of Mitoch<strong>on</strong>drial DNA Haplogroups <strong>on</strong> the Mechanical Ventilati<strong>on</strong> Weaning of Critically Ill Patients …………………………………167<br />
Yi Yang<br />
Technique Characteristics<br />
59. A Comparis<strong>on</strong> of Filter Patency in CVVHD vs Pre–Diluti<strong>on</strong>al CVVH in High Blood Flow <strong>CRRT</strong> Systems …………………………………………168<br />
Gaurav Agarwal<br />
60. Saturati<strong>on</strong> Coefficient Estimate of Peramivir in a Patient Receiving C<strong>on</strong>tinuous Veno-Venous Hemodiafiltrati<strong>on</strong> …………………………………169<br />
Michael L. Bentley<br />
61. A Retrospective Review of Transfusi<strong>on</strong> Reducti<strong>on</strong> and Cost Savings Using the Circuit to Circuit Exchange Technique in<br />
Blood Primed <strong>CRRT</strong> Circuits ………………………………………………………………………………………………………………………………170<br />
Dawn M Eding<br />
62. Treatment of Hyperlipidemia in Resistant Nephrotic Syndrome: The Effect of Combined Therapy Using Double<br />
Filtrati<strong>on</strong> Plasmapheresis and Oral Statins …………………………………………………………………………………………………………………171<br />
Dehua G<strong>on</strong>g<br />
63. BUN/Cr Change Ratio (BUN/Cr CR) as a New Delta Check Strategy for Dialysis Sample ……………………………………………………………171<br />
You Kyoung Lee<br />
64. Sustained Low Efficiency Dialysis (SLED) in India: A More Practical Alternative to <strong>CRRT</strong> …………………………………………………………172<br />
Rajiv Medanki<br />
65. A Comparis<strong>on</strong> of Estimated Creatinine Clearence and Measured Glomerular Filtrati<strong>on</strong> Rate (Tc99mDTPA clearance) in Indians ………………173<br />
Rishi Nigam<br />
66. First Intenti<strong>on</strong> C<strong>on</strong>tinuous Veno-Venous Hemodiafiltrati<strong>on</strong> in Young Children with Hemolytic and Uremic Syndrome ……………………………173<br />
Paul Nolent<br />
67. Post Filter I<strong>on</strong>ized Calcium Levels with Dilute Regi<strong>on</strong>al Citrate Anticoagulati<strong>on</strong>: Do We Need To Follow Them? …………………………………174<br />
Rajesh Speer<br />
68. Heparin Anticoagulati<strong>on</strong> in Powdered Sorbent Pheresis in Septic ICU Patients…………………………………………………………………………175<br />
RY Tan<br />
69. Plasma and Tissue Pharmacokinetics of Meropenem in Critically Ill Patients <strong>on</strong> C<strong>on</strong>tinuous Renal Replacement Therapy ………………………176<br />
Julie M Varghese<br />
70. Direct Visualizati<strong>on</strong> of Cortical Peritubular Capillary Flow Affected by Carb<strong>on</strong> Dioxide–Induced Pneumoperit<strong>on</strong>eum usinig<br />
Intravital Microscopy …………………………………………………………………………………………………………………………………………177<br />
Tokunori Yamamoto<br />
71. Regi<strong>on</strong>al Citrate Plus Low Dose of Low Molecular Weight Heparins:A Safe and More Efficacy Anticoagulati<strong>on</strong> Protocol for<br />
C<strong>on</strong>tinuous Veno-Venous Hemofiltrati<strong>on</strong> ……………………………………………………………………………………………………………………177<br />
Kaiyue Zhang<br />
RRT Research<br />
72. C<strong>on</strong>tinuous Venovenous Hemodialysis (CVVHD) Effluent Imipenem Levels Predict Plasma Free Imipenem Levels ………………………………178<br />
Seth R Bauer<br />
73. Perfluorocarb<strong>on</strong> Protects Kidney Tubular Epithelial Cells by Septic Plasma-Induced Apoptosis and Promotes CD133+ Renal<br />
Progenitor Cell Differentiati<strong>on</strong>: Relevance for Bioartificial Renal Assist Devices ………………………………………………………………………179<br />
Vincenzo Cantaluppi<br />
74. A Multiscale Model of Citrate Dynamics during Citrate Regi<strong>on</strong>al Anticoagulati<strong>on</strong> for <strong>CRRT</strong>…………………………………………………………180<br />
Steven A C<strong>on</strong>rad<br />
75. Pharmacokinetics of Imipenem in C<strong>on</strong>tinuous Venovenous Hemodialysis (CVVHD) are Related to Severity of<br />
Illness and Dialyzer Type ……………………………………………………………………………………………………………………………………180<br />
William H Fissell<br />
23
Change language